With MIDAS Disease, add a disease dimension to your market analyses. Leveraging IQVIA MIDAS, hyper-segment your market and your competitive landscape by 600 diseases and 35 tumors. This will empower better data driven decision making to achieve continual business growth.
IQVIA has established extensive data sets, networks, and partnerships and further augmented its technological capabilities through its OCE platform, which enables salesforce effectiveness and enhanced HCP targeting and segmentation. These factors helped seal IQVIA’s position as a Leader on Everest Group’s Life Sciences Sales and Marketing Operations PEAK Matrix® Assessment 2023.